Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €41.84 ($45.98) and traded as high ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Fresenius Medical Care Holdings Inc. prevailed at the First Circuit on Monday in a suit from MSP Recovery over alleged injuries linked to dialysis product GranuFlo.

The healthcare company said it had sold 3.6% of Fresenius Medical Care’s share capital and that it would use the proceeds to help strengthen its balance sheet and reduce leverage.

Fresenius SE is seeking to raise about €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt ...

The disruption is expected to impact patient care, may require adjustments to the management of hemodialysis patients and ...

Fresenius SE KGaA's (ETR:FRE) stock is up by a considerable 16% over the past three months. However, we decided to ...

(Reuters) -Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, released its 2024 Annual Report including its Sustainability Statement. By ...

Erste Group reinstated coverage of Fresenius SE (FSNUY) with a Buy rating.Discover the Best Stocks and Maximize Your Portfolio: See what stocks ...